Genentech, Inc.
NEWS
Genentech scored two approvals from the FDA this week.
The drug will be used to prevent or reduce the frequency of bleeding episodes in certain patients.
Arvinas expanded an ongoing licensing deal with Genentech.
Denali plans to make a $100M IPO under the symbol DNLI.
People diagnosed with the rare blood disorder known as Erdheim-Chester disease have a new treatment option.
It’s not uncommon for companies to announce layoffs in the final months of the year.
JOBS
IN THE PRESS